RE: Knowlesi,1 Nov 2020 08:34
Douve87
I have sympathy with your comments on Data, but Scancell has no Current data on (Particularly Moditope of any significant variety). I think that what is needed to maximise IP value is significant, fresh, up to the minute Data on where the various developments are and then (and only then) can the assets of the company come firmly into play. To achieve that costs a great deal of money. That money is available, BUT for some unknown reason the BOD is divided. It would be helpful if the naysayer/s would step up to the plate tell the shareholders what their problem is. I find it difficult to make a value judgement without knowing both sides. So rather than a resoned, informed judgement we are being asked to decide without all the information. In that situation do we simply say NO and then have our US backer possibly walk away or commit no further funds than already invested, or do we accept the cash available and hope that the BOD will somehow change from the history we know about and get real and effective development underway? Don't see much of a problem really, it seems a vote yes gives shareholders a chance, a vote no hands effective control of Scancell to those who seek to disrupt the progress whislt staying in the shadows and simply refusing to put their case up for consideration. It's a painful situation to be confronted by, but I'm not prepared to put my investment in the hands of those who want to disrupt a major cash injection but won't say why.